相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Structure and activation of C1, the complex initiating the classical pathway of the complement cascade
Simon A. Mortensen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Modulating IgG effector function by Fc glycan engineering
Tiezheng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases
Yves Marie Pers et al.
Immunotherapy (2016)
Molecular Basis of Assembly and Activation of Complement Component C1 in Complex with Immunoglobulin G1 and Antigen
Guanbo Wang et al.
MOLECULAR CELL (2016)
Multi-level glyco-engineering techniques to generate IgG with defined Fc-glycans
Gillian Dekkers et al.
SCIENTIFIC REPORTS (2016)
Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
Isaak Quast et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Heterosubtypic Antibodies to Influenza A Virus Have Limited Activity against Cell-Bound Virus but Are Not Impaired by Strain-Specific Serum Antibodies
Arkadiusz Wyrzucki et al.
JOURNAL OF VIROLOGY (2015)
In Vitro Glycoengineering of IgG1 and Its Effect on Fc Receptor Binding and ADCC Activity
Marco Thomann et al.
PLOS ONE (2015)
Multi-Angle Effector Function Analysis of Human Monoclonal IgG Glycovariants
Tetyana Dashivets et al.
PLOS ONE (2015)
Complement and Its Receptors: New Insights into Human Disease
V. Michael Holers
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Christoph A. Diebolder et al.
SCIENCE (2014)
IgG subclasses and allotypes: from structure to effector functions
Gestur Vidarsson et al.
FRONTIERS IN IMMUNOLOGY (2014)
Glycoengineered CD20 antibody obinutuzumab activates neutrophils and mediates phagocytosis through CD16B more efficiently than rituximab
Josee Golay et al.
BLOOD (2013)
Impact of Immune Complex Size and Glycosylation on IgG Binding to Human FcγRs
Anja Lux et al.
JOURNAL OF IMMUNOLOGY (2013)
High-Throughput IgG Fc N-Glycosylation Profiling by Mass Spectrometry of Glycopeptides
Maja Pucic Bakovic et al.
JOURNAL OF PROTEOME RESEARCH (2013)
Isotype and glycoform selection for antibody therapeutics
Roy Jefferis
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity
Michael A. Maurer et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Rituximab resistance
Andrew R. Rezvani et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2011)
Mechanisms and principles of N-linked protein glycosylation
Flavio Schwarz et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2011)
Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans
Tsunehiro Mizushima et al.
GENES TO CELLS (2011)
The IgG-specific endoglycosidase EndoS inhibits both cellular and complement-mediated autoimmune hemolysis
Maria Allhorn et al.
BLOOD (2010)
Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer
Teemu T. Junttila et al.
CANCER RESEARCH (2010)
Successful treatment of experimental glomerulonephritis with IdeS and EndoS, IgG-degrading streptococcal enzymes
Rui Yang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Production of therapeutic antibodies with controlled fucosylation
Naoko Yamane-Ohnuki et al.
MABS (2009)
Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
Kenneth Smith et al.
NATURE PROTOCOLS (2009)
Recombinant antibody therapeutics: the impact of glycosylation on mechanisms of action
Royston Jefferis
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning
Thomas Tiller et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Agalactosylated IgG antibodies depend on cellular Fc receptors for in vivo activity
Falk Nimmerjahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Optimization of humanized IgGs in glycoengineered Pichia pastoris
HJ Li et al.
NATURE BIOTECHNOLOGY (2006)
Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity
S Krapp et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc
EE Idusogie et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
